Cargando…
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
It is important to have accurate knowledge of the range of cancers associated with various CHEK2 mutations, and of the lifetime risks of cancer associated with each. We wished to establish the relationship between family history, mutation type and cancer risk in families with a CHEK2 mutation. We ob...
Autores principales: | Gronwald, J, Cybulski, C, Piesiak, W, Suchy, J, Huzarski, T, Byrski, T, Gorski, B, Debniak, T, Szwiec, M, Wokolowczyk, D, Matuszewski, M, Sun, P, Lubinski, J, Narod, S A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694428/ https://www.ncbi.nlm.nih.gov/pubmed/19401704 http://dx.doi.org/10.1038/sj.bjc.6605038 |
Ejemplares similares
-
The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012) -
CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012) -
Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006) -
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022) -
Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)